Guido Bonati is the new Chief Technology Officer and Head of Research & Development at FISBA AG

Guido Bonati, Head of R&D and CTO at FISBA AG since July 2020 Foto: FISBA

He structures the services required of R&D with the resources, ideas and potential and deploys efficient teams to successfully handle customer projects.

Guido Bonati was awarded a PhD in mechanical engineering, specializing in laser technology and design, at RWTH Aachen University in North Rhine-Westphalia, Germany.

He has worked in management positions all over the world for various companies in the optical industry, including in the fields of laser technology and optics, for over 25 years.

In his new position at FISBA, he can rely on his experience and in-depth knowledge in the development, production and business development fields.

Guido Bonati succeeds Christian Zellweger, who has taken up a new challenge within the company as its COO.

About FISBA Since 1957, FISBA has been supplying customers in the photonics sector with the industry’s largest range of design and manufacturing capacities for optical components and systems. Highly specialized teams satisfy the complex requirements of customers from the strictly regulated life sciences, defense and aerospace, industrial manufacturing and material processing fields and help world-leading brands fulfill their market potential. FISBA's services, which are centered on its customers, range from concept design through support in device development to engineering, supply-chain optimization and assembly. Our specially equipped branch offices that meet the strict market requirements while protecting our customers' intellectual property are ready to fulfill this purpose. FISBA runs operations at sites in Switzerland, Germany, USA and China.

Media contact
Birgit Rauch
Head of Corporate Marketing Communication
media@fisba.com

www.fisba.com

Media Contact

Birgit Rauch FISBA AG

All latest news from the category: Corporate News

Back to home

Comments (0)

Write a comment

Newest articles

Scientists identify novel molecular biomarkers in cells

Studying a deadly type of breast cancer called triple negative, Johns Hopkins Medicine scientists say they have identified key molecular differences between cancer cells that cling to an initial tumor…

Getting more out of light

Tiny crystals, known as quantum dots, have enabled an international team to achieve a quantum efficiency exceeding 100 percent in the photocurrent generated in a hybrid inorganic-organic semiconductor. Perovskites are…

Antibiotics from natural substances

A new biosynthesis method has been developed. A research team with members from Goethe University Frankfurt and the University of Michigan in the USA is using bacterial biosynthesis to produce…

Partners & Sponsors